News Coverage
This article relates to the FCS+T Group property:
Science + Technology Park at Johns Hopkins
Life sciences park lands new tenant
October 10, 2007
by Robert J. Terry, Baltimore Business Journal
A Bethesda biotechnology company has signed a deal to lease space at the first building of a life sciences research park being built in East Baltimore.
Forest City-New East Baltimore Partnership, the park's developer, said Tuesday that Cangen Biotechnologies will occupy 12,300 square feet in the building at 855 N. Wolfe St. Cangen will join the Johns Hopkins Institute for Basic Biomedical Sciences and the Howard Hughes Medical Institute in the 278,000-square-foot building, the first of five facilities planned for the Science + Technology Park at Johns Hopkins and set to open next spring.
Scott Levitan, senior vice president and director of development for the life sciences park, said in a statement the deal with Cangen builds on the development's objectives: Attracting promising biotech companies interested in utilizing the medical resources at Johns Hopkins, and at the same time transforming a blighted residential community with new housing and job opportunities.
"We are excited to be expanding our presence in East Baltimore," Lawrence Agulnick, COO of Cangen Biotechnologies, said in a statement. "I believe that close proximity to the academic and research resources of Hopkins will be of critical benefit to Cangen as we continue to commercialize diagnostic technologies developed at Hopkins."
Cangen was launched in 2000 by a Hopkins researcher to develop cancer diagnostic tests. Dr. Chulso Moon, a company founder, is a professor in the Department of Oncology, Otolaryngology, Head and Neck Surgery at the Johns Hopkins University School of Medicine.